Jump to content
Powered by
  • Dossier Advanced therapy medicinal products

    Novel gene and cell therapies are associated with high expectations in the treatment of incurable and hereditary diseases. Among them, CAR-T cell therapies have emerged as a major hope in cancer treatment.
    © BIOPRO Baden-Württemberg GmbH

  • Contact Stay in touch

    Would you like continue receiving e-mail notifications about our activities, up-to-date information, events, opportunities for cooperation and general industry information? Register here to stay informed about current issues.
    © denisismagilov / Adobe Stock

  • Industry report The healthcare industry in Baden-Württemberg

    BIOPRO's new report entitled "Healthcare Industry 2020: Facts and Figures for Baden-Württemberg" illustrates key figures like num the number of companies, number of employees and taxable turnover for the biotechnology, medical technology and pharmaceutical industry.
    © MR.LIGHTMAN / Adobe Stock

Latest news

  • Freudenberg Filtration Technologies - 01/10/2020

    Filter technology can effectively remove microorganisms such as the new coronavirus from aerosols. A team of experts at Freudenberg Filtration Technologies develops and produces filtration solutions that effectively reduce the spread of viruses in cars, industrial plants and public buildings. The company’s filter technology for reducing the viral load is a reliable method for enabling people to stay in closed rooms with a high density of people.

  • Organ failure due to fatty liver - 24/09/2020

    When the liver stops regenerating on its own, it might be possible in future for doctors to intervene with a chemical agent. Tübingen-based HepaRegeniX GmbH is developing a promising candidate with the aim of improving the treatment of both acute and chronic liver failure.

  • Mosses for pharmaceutical production - 16/09/2020

    The search for drug candidates for COVID-19 diseases is well underway. Factor H, which is part of the innate immune system, might also be a future therapeutic option. The Freiburg-based biotech company eleva has developed a technology for producing this human protein in moss cells. The active ingredient, which might also have a regulatory effect in other diseases, is currently undergoing preclinical testing.

  • Phytopharmaceuticals - 14/09/2020

    Anyone who thinks hemp is just an inconspicuous plant, whose ingredients can be used, at best, as an intoxicant, can quickly be proven wrong. Besides being used as a valuable raw material for textiles and building materials, the plant has great potential as a medicinal drug. The CANNABIS-NET network, coordinated by the University of Hohenheim, has been set up to establish the basis for producing medicinal hemp in Germany.

  • Biochip systems - 02/09/2020

    Dr. Peter Loskill and his team at the Fraunhofer Institute in Stuttgart and the University Hospital of Tübingen are developing what is known as an "organ-on-a-chip" (OoC). An OoC is a microfluidic system that simulates small functional units of organ tissue. OoCs can be used in different ways: in basic and pharmaceutical research as well as in clinical research and application, where they might render many animal experiments…

Upcoming events

Website address: https://www.gesundheitsindustrie-bw.de/en